# VitaNova Life Sciences Corp

VitaNova Life Sciences Corp is a public company listed on OTC as VNOV, headquartered in New York, NY, United States.

## Company overview

- **Legal name:** VitaNova Life Sciences Corp
- **Former names in filing history:** YIJIA GROUP CORP. (2019-07-30 to 2026-01-13); YIJIA GROUP CORP (2018-12-14 to 2019-07-29); Soldino Group Corp (2017-06-14 to 2018-11-26)
- **Classification:** Public company
- **Industry (SIC):** 5130 — Wholesale-Apparel, Piece Goods & Notions
- **Headquarters:** New York, NY, United States
- **Incorporated in:** NV
- **Fiscal year end:** April 30
- **Ticker:** OTC: VNOV
- **SEC CIK:** 0001699709

## About

VitaNova Life Sciences Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001699709, and its reported industry is Wholesale-Apparel, Piece Goods & Notions. In 10-K filed on 2026-07-29, it reported annual revenue of USD 3,025,538; net income of USD -37,304; total assets of USD 2,446,561 for the fiscal period ended 2026-04-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2026 (period ended 2026-04-30)

- **Revenue:** $3.0M (USD 3,025,538)
- **Net income:** -$37,304 (USD -37,304)
- **Total assets:** $2.4M (USD 2,446,561)
- **Operating cash flow:** $814,407 (USD 814,407)

### FY2025 (period ended 2025-04-30)

- **Revenue:** $2.7M (USD 2,662,105)
- **Net income:** $850,746 (USD 850,746)
- **Total assets:** $2.3M (USD 2,256,251)
- **Operating cash flow:** $192,774 (USD 192,774)

### FY2024 (period ended 2024-04-30)

- **Revenue:** $570,694 (USD 570,694)
- **Net income:** $140,865 (USD 140,865)
- **Total assets:** $1.2M (USD 1,192,858)
- **Operating cash flow:** -$375,880 (USD -375,880)

### FY2023 (period ended 2023-04-30)

- **Revenue:** $38,000 (USD 38,000)
- **Net income:** -$24,227 (USD -24,227)
- **Total assets:** $8,728 (USD 8,728)
- **Cash and equivalents:** $8,728 (USD 8,728)
- **Operating cash flow:** -$18,375 (USD -18,375)

## Recent SEC filings

- Form 10-Q — filed 2026-09-14 — period 2026-07-31 — FORM 10-Q FOR JUL 2026
- Form 10-K — filed 2026-07-29 — period 2026-04-30 — FORM 10-K FOR APR 2026
- Form 8-K — filed 2026-03-18 — period 2026-03-12 — CURRENT REPORT
- Form 10-Q — filed 2026-03-16 — period 2026-01-31 — FORM 10-Q FOR JAN 2026
- Form 8-K — filed 2026-02-25 — period 2026-02-19 — CURRENT REPORT
- Form 8-K — filed 2026-01-27 — period 2026-01-27 — CURRENT REPORT
- Form 8-K — filed 2026-01-13 — period 2026-01-09 — FORM 8-K
- Form 10-Q — filed 2025-12-15 — period 2025-10-31 — FORM 10-Q FOR OCT 2025
- Form 8-K — filed 2025-10-07 — period 2025-10-07 — FORM 8-K
- Form 10-Q — filed 2025-09-12 — period 2025-07-31 — FORM 10-Q FOR JULY 2025
- Form 10-K — filed 2025-07-24 — period 2025-04-30 — FORM 10-K FOR APRIL 2025
- Form 10-Q — filed 2025-03-17 — period 2025-01-31 — FORM 10-Q FOR JAN 2025

---

Updated: 2026-10-23T06:52:41Z

Canonical page: https://altss.com/profile/vitanova-life-sciences-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology